TDP-43 mutations, also found in a proportion of ALS and FTD cases, yield cytoplasmic aggregates that mislocalise nucleo-cytoplasmic regulators, hence amplifying nuclear transport defects (Chou et al., 2018; Gasset-Rosa et al., 2019). Here, TARDBP is linked to amyotrophic lateral sclerosis.